1.
Searle E, Lesokhin A, Niesvizky R, Arnulf B, Larson S, Strouse C, Fernandez De Larrea C, Vesole D, Nagai Y, Sullivan S, Leip E, Bahlis N. P35 | PROLONGED ELRANATAMAB TREATMENT INTERRUPTION IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A MagnetisMM-3 RETROSPECTIVE ANALYSIS. Haematologica 2026; 111(s2); https://doi.org/10.3324/haematol.2026.s2.14090.